As shown in Figure 6A-B, in CCA cells, the HSP90 inhibitor significantly reversed the up-regulation of HIF1A protein expression caused by USP21 overexpression, and thus reversed the protein and mRNA expression levels of glycolytic enzyme genes ENO2, ENO3, ALDOC, and ACSS2. The gene discussed is USP21; the disease is cholangiocarcinoma.